{"contract_version": "company-research-1", "available": true, "found": true, "as_of": "2026-09-25", "dates": {"factor_edition": "2026-09-25", "company_period_end": "2026-06-30", "weekly_chart": "2026-10-02", "latest_completed_week": "2026-10-02"}, "universe": {"id": "EUR_DE", "name": "Germany - EUR"}, "company": {"uuid": "5bad3c49-1a5d-4198-b66b-629b0d1b7565", "symbol": "MED", "name": "MEDICLIN Aktiengesellschaft", "exchange": "GER", "sector": "Healthcare", "combined_standing": 99.0, "change_points": -0.0, "coverage_percent": 100.0, "reading": "Value finding support", "insight": "Value and business strength are joined by stronger price standing.", "watch": "Check whether weekly trend and participation support the price ranking.", "pillar_standing": {"value": 97.0, "quality": 83.0, "momentum": 93.0, "growth": 59.0, "yield": 9.0}}, "focus": {"preset": "piotroski_bargains", "name": "Piotroski Bargains", "question": "Is company improvement supporting a value case?", "headline": "Value leads; business strength needs scrutiny", "insight": "3 of 3 measured focus pillars have standing of at least 65. Compare the weaker readings with their own history before treating the case as complete.", "latest_change": "0 improving, 0 weakening and 3 unchanged across the 3 comparable focus pillars since the previous edition.", "qualifies": true, "screen_position": 8, "screen_companies": 123, "primary_standing": {"key": "quality", "label": "Business strength", "value": 83.0}, "breadth": {"strong_pillars": 3, "measured_pillars": 3}, "pillars": [{"key": "quality", "label": "Business strength", "value": 83.0, "median": 69.0, "gap": 14.0, "strong_share": 100, "observations": 17}, {"key": "value", "label": "Value", "value": 97.0, "median": 79.0, "gap": 18.0, "strong_share": 100, "observations": 17}, {"key": "momentum", "label": "Price strength", "value": 93.0, "median": 51.0, "gap": 42.0, "strong_share": 100, "observations": 17}]}, "market_confirmation": {"available": true, "reading": "3 of 3 available weekly market readings are positive. Company standing and the latest chart evidence reinforce one another.", "positive": 3, "measured": 3}, "playbook": {"strengthens_case": "Value and business strength hold together", "weakens_case": "One side of the combination gives way", "watch_next": "Monitor the weaker of value and business strength; use price support as a separate confirmation check."}, "screen_membership": [{"preset": "os_top", "name": "Strong combined scores"}, {"preset": "trending_value_vc2", "name": "Value with price strength"}, {"preset": "deep_value", "name": "Deep Value"}, {"preset": "vc2_cheapest", "name": "Lowest valuation group"}, {"preset": "quality_value", "name": "Value with financial strength"}, {"preset": "shareholder_yield", "name": "Shareholder Yield"}, {"preset": "ebitda_ev", "name": "EBITDA/EV Value"}, {"preset": "trending_value", "name": "Value with six-month strength"}, {"preset": "piotroski_bargains", "name": "Piotroski Bargains"}, {"preset": "momentum_leaders", "name": "Price leaders"}, {"preset": "risk_adj_momentum", "name": "Price strength relative to volatility"}, {"preset": "small_cap_value", "name": "Small Cap Value"}, {"preset": "sector_value_leaders", "name": "Strong value ranks"}, {"preset": "sector_relative", "name": "Sector value leaders"}, {"preset": "cash_generators", "name": "Cash generators"}], "links": {"canonical": "https://sharemaestro.com/factors/ticker/5bad3c49-1a5d-4198-b66b-629b0d1b7565/", "report": "https://sharemaestro.com/factors/ticker/5bad3c49-1a5d-4198-b66b-629b0d1b7565/?universe=EUR_DE&preset=piotroski_bargains", "screener": "https://sharemaestro.com/factors/?universe=EUR_DE&preset=piotroski_bargains", "chart": "https://sharemaestro.com/terminal/5bad3c49-1a5d-4198-b66b-629b0d1b7565/"}, "limitations": ["Factor standing is relative to the named universe; higher is stronger. It is not a probability or expected return.", "Factor edition, company period and weekly chart dates can differ. New prices do not imply new company inputs.", "Historical observations are not an investable point-in-time backtest. Missing evidence is unavailable, not zero.", "Research conditions describe evidence to monitor, not instructions to buy or sell."]}